Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of SARS-CoV-2 Antibody Response After Vaccination in Liver Transplant Recipients Who Undergo Tailored Immunosuppression Therapy

NCT05490342 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT05490342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05490342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of SARS-CoV-2 Antibody Response After Vaccination in Liver Transplant Recipients Who Undergo Tailored Immunosuppression Therapy
Lead sponsor
University of Rome Tor Vergata
Phase
Observational
Overall status
Completed
Start date
April 1, 2022
Completion date
June 30, 2022
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation, sars-cov-2 vaccination